PepEvolutionHumanin
A mitochondrial-derived peptide with intriguing aging biology but essentially no interventional human evidence.
Verdict — D · Speculative
Compelling aging-biology science, but the case for buying and injecting it is not there — the human data are observational, not interventional, and sourcing is hard to verify. Speculative, for the research-minded only.
Overview
Humanin is a 24-amino-acid mitochondrial-derived peptide with cytoprotective and metabolic signalling roles, and is a genuinely interesting subject in aging biology — higher endogenous levels have been associated with longevity in observational work. However, the human evidence is observational and mechanistic rather than interventional: there are essentially no controlled trials of administered humanin, so its efficacy and safety as an injectable are unestablished. Sourcing of a verifiable version is difficult.
PepScore Breakdown — the four axes
Evidence
35% weightHow strong is the published human science?
Sourcing & COA
30% weightOur moatCan a buyer obtain an independently-verified, high-purity version? — our proprietary layer.
Safety & Risk
25% weightWhat is the real-world harm potential?
Practicality
10% weightHow easy is it to actually run a verified version?
Sources & Citations
Every claim cites a primary source. Citations are machine-audited against NCBI — see methodology.
Educational only — not medical advice. PepScore is an educational research grade, not a prescription or dosing recommendation. Some vendor links are affiliate links — this never affects grades. Consult a licensed healthcare provider before using any compound.